Atlas Trials

A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath

Clinical trial NCT04794218 · UNKNOWN

Trial details

NCT number
NCT04794218
Sponsor
International AIDS Vaccine Initiative
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lassa FeverLassa Virus Infection
Start date
2021-06-23
Primary completion
2023-12-19
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.